Removals and corrections
This article was originally published in The Gray Sheet
Executive Summary
FDA direct-to-final rule published in the Aug. 7 Federal Register implementing Sec. 213 of the FDA Modernization Act states that distributors will no longer be required to report to the agency corrections and removals of medical devices. The final date FDA will accept comments on the direct-to-final rule is Oct. 21